Nurse practitioner Tracey Dennison has unveiled the Menopause Advocacy Training course for healthcare professionals. According to Dennison the one-day course provides a broad, generalist approach to menopause education, equipping clinicians
Skincare company Revision Skincare has launched its Triple-Action Exfoliator. Available through aesthetic distributor AestheticSource, Revision Skincare shares that the product is designed to address dead skin cells across surface and
Tameside Metropolitan Borough Council (TMBC) has issued letters threatening legal action to non-medics offering non-surgical cosmetic treatments in the borough. The letters reminded businesses of the legal requirements surrounding these
Charity organisation Children’s Burns Trust has celebrated 25 years and launched its new campaign. According to the organisation, it has provided emergency grants, family rehabilitation weekends and nationwide prevention campaigns
Aesthetic manufacturer Teoxane has launched the Urban Shield SPF30. According to the company, the SPF protects against UV radiation, blue light, pollution and oxidative stress. Formulated with Teoxane’s Resilient Hyaluronic
The Medicines and Healthcare products Regulatory Agency (MHRA), working alongside the Advertising Standards Authority (ASA) and the General Pharmaceutical Council (GPhC), has released an updated Enforcement Notice this week to
Aesthetic distribution company AestheticSource invited press and practitioners to a session and panel discussion at Soho House, London on October 1. The afternoon commenced with an address from Lorna Bowes,
The Non-Surgical Procedures and Functions of Medical Reviewers Bill has been introduced to the Scottish Parliament. According to the Scottish Parliament, the Bill was introduced to ensure that non-surgical procedures
Aesthetic Dialogue 2025 is scheduled to take place at Prague Castle in the Czech Republic from November 15-16. Now in its third year, the symposium is a programme focused on
Pharmaceutical company IBSA Derma, the UK and Ireland subsidiary of global pharmaceutical leader IBSA, has announced that it will assume responsibility for the distribution of injectables Profhilo, Aliaxin and Viscoderm.
